Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6B39
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,809
Award facts
- Contract value 100% obligated
- $10,809.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,809.06 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes on February 4, 2026, with an ultimate completion date of February 5, 2026. The award is a firm fixed-price contract with no set-aside designation, indicating competitive procurement on a full and open basis. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including eczema, asthma, and chronic rhinosinusitis, and its procurement reflects the Defense Logistics Agency's medical supply needs for military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The parent IDC serves as a comprehensive pharmaceutical and medical supply vehicle supporting military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. AmerisourceBergen's role as a prime pharmaceutical vendor demonstrates its established capability to fulfill federal medical procurement requirements efficiently and competitively.
Quick answers
Who was awarded contract SPE2DR26F6B39?
SPE2DR26F6B39 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F6B39 worth?
The government has obligated $10,809 on SPE2DR26F6B39.
Is contract SPE2DR26F6B39 an order under another contract?
Yes. SPE2DR26F6B39 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F6B39 competed?
The extent of competition for SPE2DR26F6B39 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award